EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

医学 膀胱镜检查 膀胱癌 原位癌 泌尿科 化疗 尿路上皮癌 癌症 肿瘤科 内科学 泌尿系统
作者
Marko Babjuk,Maximilian Burger,Richard Zigeuner,Shahrokh F. Shariat,Bas W.G. van Rhijn,Éva Compérat,Richard Sylvester,Eero Kaasinen,Andreas Böhle,Joan Palou Redorta,Morgan Rouprêt
出处
期刊:European Urology [Elsevier]
卷期号:64 (4): 639-653 被引量:1117
标识
DOI:10.1016/j.eururo.2013.06.003
摘要

The first European Association of Urology (EAU) guidelines on bladder cancer were published in 2002 [1]. Since then, the guidelines have been continuously updated. To present the 2013 EAU guidelines on non–muscle-invasive bladder cancer (NMIBC). Literature published between 2010 and 2012 on the diagnosis and treatment of NMIBC was systematically reviewed. Previous guidelines were updated, and the levels of evidence and grades of recommendation were assigned. Tumours staged as Ta, T1, or carcinoma in situ (CIS) are grouped as NMIBC. Diagnosis depends on cystoscopy and histologic evaluation of the tissue obtained by transurethral resection (TUR) in papillary tumours or by multiple bladder biopsies in CIS. In papillary lesions, a complete TUR is essential for the patient's prognosis. Where the initial resection is incomplete, where there is no muscle in the specimen, or where a high-grade or T1 tumour is detected, a second TUR should be performed within 2–6 wk. The risks of both recurrence and progression may be estimated for individual patients using the EORTC scoring system and risk tables. The stratification of patients into low-, intermediate-, and high-risk groups is pivotal to recommending adjuvant treatment. For patients with a low-risk tumour, one immediate instillation of chemotherapy is recommended. Patients with an intermediate-risk tumour should receive one immediate instillation of chemotherapy followed by 1 yr of full-dose bacillus Calmette-Guérin (BCG) intravesical immunotherapy or by further instillations of chemotherapy for a maximum of 1 yr. In patients with high-risk tumours, full-dose intravesical BCG for 1–3 yr is indicated. In patients at highest risk of tumour progression, immediate radical cystectomy should be considered. Cystectomy is recommended in BCG-refractory tumours. The long version of the guidelines is available from the EAU Web site: http://www.uroweb.org/guidelines/. These abridged EAU guidelines present updated information on the diagnosis and treatment of NMIBC for incorporation into clinical practice. The EAU Panel on Non-muscle Invasive Bladder Cancer released an updated version of their guidelines. Current clinical studies support patient selection into different risk groups; low, intermediate and high risk. These risk groups indicate the likelihood of the development of a new (recurrent) cancer after initial treatment (endoscopic resection) or progression to more aggressive (muscle-invasive) bladder cancer and are most important for the decision to provide chemo- or immunotherapy (bladder installations). Surgical removal of the bladder (radical cystectomy) should only be considered in patients who have failed chemo- or immunotherapy, or who are in the highest risk group for progression.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
十二发布了新的文献求助10
1秒前
补喵发布了新的文献求助10
1秒前
丘比特应助努力毕业ing采纳,获得10
3秒前
华仔应助努力毕业ing采纳,获得10
3秒前
Orange应助平常从蓉采纳,获得10
4秒前
文安完成签到 ,获得积分10
5秒前
6秒前
直率的宛海完成签到,获得积分10
7秒前
怡然的小萱完成签到 ,获得积分10
7秒前
菠萝发布了新的文献求助10
8秒前
gmy完成签到,获得积分20
8秒前
9秒前
10秒前
11秒前
苏乂发布了新的文献求助10
12秒前
13秒前
我我我完成签到,获得积分10
14秒前
15秒前
努力毕业ing完成签到,获得积分10
17秒前
闻歌发布了新的文献求助10
18秒前
18秒前
毛毛完成签到,获得积分10
20秒前
IAMXC发布了新的文献求助10
20秒前
王晓雪完成签到,获得积分10
21秒前
小二郎应助newgeno2003采纳,获得10
22秒前
十二完成签到,获得积分10
23秒前
baifeng完成签到 ,获得积分10
25秒前
阿拉阿拉赛完成签到,获得积分10
25秒前
舒适店员完成签到 ,获得积分10
26秒前
嘿嘿嘿完成签到,获得积分10
26秒前
一只想做科研的狗完成签到,获得积分10
27秒前
浅尝离白应助琛哥物理采纳,获得10
27秒前
27秒前
28秒前
zhuo完成签到,获得积分20
29秒前
YY发布了新的文献求助10
29秒前
zjy完成签到,获得积分10
29秒前
小蘑菇应助闻歌采纳,获得10
30秒前
30秒前
30秒前
高分求助中
The Oxford Handbook of Social Cognition (Second Edition, 2024) 1050
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Chen Hansheng: China’s Last Romantic Revolutionary 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3140718
求助须知:如何正确求助?哪些是违规求助? 2791628
关于积分的说明 7799729
捐赠科研通 2447921
什么是DOI,文献DOI怎么找? 1302210
科研通“疑难数据库(出版商)”最低求助积分说明 626473
版权声明 601194